Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer

NCT07686640 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Local Advanced Rectal Cancer
Radiotherapy
Immunotherapy

Interventions

RADIATION: Short-Course Radiotherapy
DRUG: Consolidation treatment (With ICIs)
DRUG: Consolidation treatment (Without ICIs)

Sponsor

Shandong Cancer Hospital and Institute